Raymond James & Associates’s Arvinas ARVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-6,491
Closed -$289K 3923
2022
Q3
$289K Sell
6,491
-172
-3% -$8.35K ﹤0.01% 3205
2022
Q2
$280K Sell
6,663
-23
-0.3% -$1.15K ﹤0.01% 3280
2022
Q1
$450K Buy
6,686
+1,172
+21% +$79.9K ﹤0.01% 3130
2021
Q4
$453K Sell
5,514
-1,062
-16% -$86.4K ﹤0.01% 3161
2021
Q3
$540K Sell
6,576
-253
-4% -$22.4K ﹤0.01% 3008
2021
Q2
$526K Sell
6,829
-26
-0.4% -$1.8K ﹤0.01% 3041
2021
Q1
$453K Buy
+6,855
New +$524K ﹤0.01% 3092

Other funds holding ARVN

Raymond James & Associates's ARVN Position: Q4 2022 in Review

Raymond James & Associates sold out of Arvinas (ARVN) in Q4 2022, closing a stake of 6,491 shares — an estimated $289K sold.

Raymond James & Associates first reported a position in ARVN in Q1 2021 and held it in 7 quarters. The position peaked at $540K in Q3 2021. 162 funds tracked by Wall St. Rank hold ARVN as of Q4 2022.

  • Raymond James & Associates reported no remaining Arvinas position as of Q4 2022 after selling out during the quarter.
  • Raymond James & Associates sold 6,491 Arvinas shares in Q4 2022, an estimated $289K.
  • Raymond James & Associates first reported a position in Arvinas in Q1 2021 and held it in 7 quarters.
  • Raymond James & Associates's Arvinas position peaked at $540K in Q3 2021.
  • 162 funds tracked by Wall St. Rank held Arvinas as of Q4 2022.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.